Masayuki Shirakura

2.1k total citations
48 papers, 1.2k citations indexed

About

Masayuki Shirakura is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Masayuki Shirakura has authored 48 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Epidemiology, 18 papers in Infectious Diseases and 11 papers in Hepatology. Recurrent topics in Masayuki Shirakura's work include Influenza Virus Research Studies (28 papers), Respiratory viral infections research (21 papers) and Viral gastroenteritis research and epidemiology (9 papers). Masayuki Shirakura is often cited by papers focused on Influenza Virus Research Studies (28 papers), Respiratory viral infections research (21 papers) and Viral gastroenteritis research and epidemiology (9 papers). Masayuki Shirakura collaborates with scholars based in Japan, United States and Mongolia. Masayuki Shirakura's co-authors include Takato Odagiri, Noriko Kishida, Seiichiro Fujisaki, Takaji Wakita, Kazuya Nakamura, Emi Takashita, Shinji Watanabe, Tomoko Kuwahara, Hiroko Morita and Rie Ogawa and has published in prestigious journals such as PLoS ONE, Journal of Virology and Biochemical and Biophysical Research Communications.

In The Last Decade

Masayuki Shirakura

45 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masayuki Shirakura Japan 21 734 317 313 235 166 48 1.2k
Kouacou V. Konan United States 19 379 0.5× 433 1.4× 153 0.5× 304 1.3× 263 1.6× 23 1.1k
Christian Castro United States 14 295 0.4× 634 2.0× 371 1.2× 276 1.2× 48 0.3× 23 1.2k
Chia-Yi Yu Taiwan 19 279 0.4× 444 1.4× 651 2.1× 111 0.5× 422 2.5× 37 1.5k
Laurène Meyniel‐Schicklin France 14 345 0.5× 420 1.3× 199 0.6× 80 0.3× 233 1.4× 18 893
Kiyoshi Himmelsbach Germany 21 537 0.7× 354 1.1× 186 0.6× 506 2.2× 188 1.1× 26 1.2k
Mohamed Lamine Hafirassou France 10 293 0.4× 244 0.8× 424 1.4× 170 0.7× 180 1.1× 11 1.0k
Simon P. Tucker United States 20 414 0.6× 313 1.0× 298 1.0× 23 0.1× 131 0.8× 34 1.0k
Suganya Selvarajah United States 12 399 0.5× 529 1.7× 248 0.8× 313 1.3× 203 1.2× 20 1.3k
Eike R. Hrincius Germany 19 688 0.9× 364 1.1× 238 0.8× 25 0.1× 605 3.6× 35 1.2k
Stephen M. Laidlaw United Kingdom 16 366 0.5× 279 0.9× 151 0.5× 54 0.2× 246 1.5× 28 981

Countries citing papers authored by Masayuki Shirakura

Since Specialization
Citations

This map shows the geographic impact of Masayuki Shirakura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masayuki Shirakura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masayuki Shirakura more than expected).

Fields of papers citing papers by Masayuki Shirakura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masayuki Shirakura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masayuki Shirakura. The network helps show where Masayuki Shirakura may publish in the future.

Co-authorship network of co-authors of Masayuki Shirakura

This figure shows the co-authorship network connecting the top 25 collaborators of Masayuki Shirakura. A scholar is included among the top collaborators of Masayuki Shirakura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masayuki Shirakura. Masayuki Shirakura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Takashita, Emi, Kanju Saka, Hiroko Morita, et al.. (2025). Impact of the polymerase acidic protein E199K substitution in influenza A viruses on baloxavir susceptibility. Antiviral Research. 239. 106173–106173. 1 indexed citations
2.
Ikeda, Ryoukichi, Yuta Kobayashi, Masayuki Shirakura, et al.. (2023). Management of cholesterol granuloma due to eosinophilic otitis media using large ventilation tube. Auris Nasus Larynx. 50(6). 960–963.
3.
Matsuyama, Shutoku, Masayuki Shirakura, Yasushi Suzuki, et al.. (2023). Use of the particle agglutination/particle agglutination inhibition test for antigenic analysis of SARS‐CoV‐2. Influenza and Other Respiratory Viruses. 17(2). e13093–e13093. 2 indexed citations
4.
Nagata, Noriyo, Tomoyuki Homma, Hiroki Maeda, et al.. (2022). Immunogenicity and protective efficacy of SARS-CoV-2 recombinant S-protein vaccine S-268019-b in cynomolgus monkeys. Vaccine. 40(31). 4231–4241. 11 indexed citations
5.
Tanikawa, Taichiro, Yuko Uchida, Nobuhiro Takemae, et al.. (2018). Pathogenicity of two novel human-origin H7N9 highly pathogenic avian influenza viruses in chickens and ducks. Archives of Virology. 164(2). 535–545. 4 indexed citations
6.
Takashita, Emi, Hiroko Morita, Rie Ogawa, et al.. (2018). Susceptibility of Influenza Viruses to the Novel Cap-Dependent Endonuclease Inhibitor Baloxavir Marboxil. Frontiers in Microbiology. 9. 3026–3026. 66 indexed citations
7.
Takashita, Emi, Seiichiro Fujisaki, Masayuki Shirakura, et al.. (2016). Influenza A(H1N1)pdm09 virus exhibiting enhanced cross-resistance to oseltamivir and peramivir due to a dual H275Y/G147R substitution, Japan, March 2016. Eurosurveillance. 21(24). 25 indexed citations
8.
Nakamura, Kazuya, Masayuki Shirakura, Yasushi Suzuki, et al.. (2015). Development of a high-yield reassortant influenza vaccine virus derived from the A/Anhui/1/2013 (H7N9) strain. Vaccine. 34(3). 328–333. 12 indexed citations
9.
Li, Tian‐Cheng, Tingting Yang, Yasushi Ami, et al.. (2014). Complete Genome of Hepatitis E Virus from Laboratory Ferrets. Emerging infectious diseases. 20(4). 709–712. 23 indexed citations
10.
Takebe, Yutaka, Carrie J. Saucedo, Garry Lund, et al.. (2013). Antiviral Lectins from Red and Blue-Green Algae Show Potent In Vitro and In Vivo Activity against Hepatitis C Virus. PLoS ONE. 8(5). e64449–e64449. 107 indexed citations
11.
Yang, Tingting, Michiyo Kataoka, Yasushi Ami, et al.. (2013). Characterization of self-assembled virus-like particles of ferret hepatitis E virus generated by recombinant baculoviruses. Journal of General Virology. 94(12). 2647–2656. 26 indexed citations
12.
Suzuki, Ryosuke, Kenji Saito, Takanobu Kato, et al.. (2012). Trans-complemented hepatitis C virus particles as a versatile tool for study of virus assembly and infection. Virology. 432(1). 29–38. 26 indexed citations
13.
Uchida, Yuko, Yasushi Suzuki, Masayuki Shirakura, et al.. (2012). Genetics and infectivity of H5N1 highly pathogenic avian influenza viruses isolated from chickens and wild birds in Japan during 2010–11. Virus Research. 170(1-2). 109–117. 22 indexed citations
14.
Ujike, Makoto, Masatsugu Obuchi, Tsutomu Kageyama, et al.. (2010). Oseltamivir-Resistant Influenza Viruses A (H1N1) during 2007–2009 Influenza Seasons, Japan. Emerging infectious diseases. 16(6). 926–935. 42 indexed citations
15.
Suzuki, Ryosuke, Kohji Moriishi, Masayuki Shirakura, et al.. (2008). Proteasomal Turnover of Hepatitis C Virus Core Protein Is Regulated by Two Distinct Mechanisms: a Ubiquitin-Dependent Mechanism and a Ubiquitin-Independent but PA28γ-Dependent Mechanism. Journal of Virology. 83(5). 2389–2392. 54 indexed citations
16.
Ishii, Koji, Kyoko Murakami, Bin Zhang, et al.. (2008). Trans-encapsidation of hepatitis C virus subgenomic replicon RNA with viral structure proteins. Biochemical and Biophysical Research Communications. 371(3). 446–450. 24 indexed citations
17.
Shirakura, Masayuki, Kyoko Murakami, Tohru Ichimura, et al.. (2006). E6AP Ubiquitin Ligase Mediates Ubiquitylation and Degradation of Hepatitis C Virus Core Protein. Journal of Virology. 81(3). 1174–1185. 104 indexed citations
18.
Shirakura, Masayuki, Makoto Inoue, Satoshi Fujikawa, et al.. (2004). Postischemic administration of Sendai virus vector carrying neurotrophic factor genes prevents delayed neuronal death in gerbils. Gene Therapy. 11(9). 784–790. 47 indexed citations
19.
Inoue, Makoto, Yumiko Tokusumi, Hiroshi Ban, et al.. (2004). Recombinant Sendai virus vectors deleted in both the matrix and the fusion genes: efficient gene transfer with preferable properties. The Journal of Gene Medicine. 6(10). 1069–1081. 26 indexed citations
20.
Shirakura, Masayuki, Masayuki Fukumura, Makoto Inoue, et al.. (2003). Sendai Virus Vector-mediated Gene Transfer of Glial Cell Line-Derived Neurotrophic Factor Prevents Delayed Neuronal Death after Transient Global Ischemia in Gerbils.. EXPERIMENTAL ANIMALS. 52(2). 119–127. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026